Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

GSK Net Income 2010-2025 | GSK

GSK annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • GSK net income for the quarter ending March 31, 2025 was $2.045B, a 54.21% increase year-over-year.
  • GSK net income for the twelve months ending March 31, 2025 was $4.010B, a 28.99% decline year-over-year.
  • GSK annual net income for 2024 was $3.291B, a 46.32% decline from 2023.
  • GSK annual net income for 2023 was $6.13B, a 66.86% decline from 2022.
  • GSK annual net income for 2022 was $18.499B, a 206.79% increase from 2021.
  
GSK Annual Net Income
(Millions of US $)
2024 $3,291
2023 $6,130
2022 $18,499
2021 $6,030
2020 $7,382
2019 $5,931
2018 $4,836
2017 $1,974
2016 $1,236
2015 $12,877
2014 $4,666
2013 $8,807
2012 $7,520
2011 $8,757
2010 $2,865
2009 $8,877
GSK Quarterly Net Income
(Millions of US $)
2025-03-31 $2,045
2024-12-31 $559
2024-09-30 $-75
2024-06-30 $1,480
2024-03-31 $1,326
2023-12-31 $433
2023-09-30 $1,853
2023-06-30 $2,033
2023-03-31 $1,810
2022-12-31 $2,880
2022-09-30 $12,149
2022-06-30 $1,052
2022-03-31 $2,418
2021-12-31 $990
2021-09-30 $1,611
2021-06-30 $1,950
2021-03-31 $1,480
2020-12-31 $962
2020-09-30 $1,607
2020-06-30 $2,808
2020-03-31 $2,005
2019-12-31 $1,697
2019-09-30 $1,914
2019-06-30 $1,239
2019-03-31 $1,081
2018-12-31 $1,325
2018-09-30 $1,848
2018-06-30 $600
2018-03-31 $1,063
2017-12-31 $-678
2017-09-30 $1,587
2017-06-30 $-230
2017-03-31 $1,296
2016-12-31 $319
2016-09-30 $1,061
2016-06-30 $-624
2016-03-31 $404
2015-12-31 $-541
2015-09-30 $834
2015-06-30 $228
2015-03-31 $12,248
2014-12-31 $1,556
2014-09-30 $648
2014-06-30 $1,114
2014-03-31 $1,123
2013-12-31 $3,924
2013-09-30 $1,566
2013-06-30 $1,605
2013-03-31 $1,466
2012-12-31 $1,370
2012-09-30 $1,807
2012-06-30 $1,981
2012-03-31 $2,139
2011-12-31 $1,972
2011-09-30 $2,191
2011-06-30 $1,802
2011-03-31 $2,442
2010-12-31 $-1,116
2010-09-30 $2,082
2010-06-30 $-427
2010-03-31 $2,056
2009-12-31 $2,724
2009-09-30 $2,251
2009-06-30 $2,262
2009-03-31 $1,681
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $80.301B $40.096B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.934B 16.19
Amgen (AMGN) United States $146.202B 13.10
Gilead Sciences (GILD) United States $132.777B 13.79
Vertex Pharmaceuticals (VRTX) United States $111.458B 0.00
Bristol Myers Squibb (BMY) United States $95.710B 6.41
CSL (CSLLY) Australia $76.660B 0.00
Regeneron Pharmaceuticals (REGN) United States $64.439B 15.64
Alnylam Pharmaceuticals (ALNY) United States $37.682B 0.00
Argenex SE (ARGX) Netherlands $35.502B 96.91
BioNTech SE (BNTX) Germany $23.816B 0.00
BeiGene (ONC) Cayman Islands $23.648B 0.00
Royalty Pharma (RPRX) United States $18.625B 7.67
Biogen (BIIB) United States $18.506B 7.98
Genmab (GNMSF) Denmark $13.767B 14.08
Genmab (GMAB) Denmark $13.485B 15.13
Illumina (ILMN) United States $12.749B 24.19
Incyte (INCY) United States $12.487B 94.87
Insmed (INSM) United States $12.050B 0.00
Exelixis (EXEL) United States $11.688B 19.84
BioMarin Pharmaceutical (BMRN) United States $11.125B 18.07
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Exact Sciences (EXAS) United States $10.654B 0.00
Moderna (MRNA) United States $10.334B 0.00
Ascendis Pharma (ASND) Denmark $9.758B 0.00
QIAGEN (QGEN) Netherlands $9.407B 18.30
Roivant Sciences (ROIV) United Kingdom $7.806B 0.00
Bio-Techne Corp (TECH) United States $7.418B 27.67
Revolution Medicines (RVMD) United States $7.227B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.767B 75.75
Jazz Pharmaceuticals (JAZZ) Ireland $6.645B 6.41
Halozyme Therapeutics (HALO) United States $6.623B 12.68
Blueprint Medicines (BPMC) United States $6.480B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.188B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $5.745B 0.00
Telix Pharmaceuticals (TLX) Australia $5.475B 0.00
TG Therapeutics (TGTX) United States $5.436B 142.67
Legend Biotech (LEGN) United States $5.338B 0.00
Nuvalent (NUVL) United States $5.243B 0.00
Axsome Therapeutics (AXSM) United States $5.138B 0.00
Alkermes (ALKS) Ireland $4.955B 13.30
ADMA Biologics Inc (ADMA) United States $4.813B 36.00
Guardant Health (GH) United States $4.590B 0.00
Zealand Pharma (ZLDPF) Denmark $4.428B 0.00
Vaxcyte (PCVX) United States $4.380B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.945B 0.00
Akero Therapeutics (AKRO) United States $3.904B 0.00
Sarepta Therapeutics (SRPT) United States $3.812B 0.00
Avidity Biosciences (RNA) United States $3.713B 0.00
Cytokinetics (CYTK) United States $3.641B 0.00
Krystal Biotech (KRYS) United States $3.621B 27.90
PTC Therapeutics (PTCT) United States $3.608B 6.28
ACADIA Pharmaceuticals (ACAD) United States $3.607B 31.69
Arcellx (ACLX) United States $3.594B 0.00
Zai Lab (ZLAB) China $3.586B 0.00
SpringWorks Therapeutics (SWTX) United States $3.486B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.357B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.241B 0.00
Viking Therapeutics (VKTX) United States $3.114B 0.00
Alvotech (ALVO) Luxembourg $2.997B 17.14
Metsera (MTSR) United States $2.946B 0.00
Scholar Rock Holding (SRRK) United States $2.892B 0.00
Merus (MRUS) Netherlands $2.879B 0.00
Protagonist Therapeutics (PTGX) United States $2.846B 61.21
Immunovant (IMVT) United States $2.473B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.465B 0.00
ImmunityBio (IBRX) United States $2.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.340B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.313B 0.00
Apellis Pharmaceuticals (APLS) United States $2.235B 0.00
Ascentage Pharma Group - (AAPG) China $2.225B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.182B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.125B 0.00
Vericel (VCEL) United States $2.083B 1379.33
Belite Bio (BLTE) United States $2.058B 0.00
NovoCure (NVCR) Jersey $2.019B 0.00
Bavarian Nordic (BVNRY) Denmark $2.011B 10.62
Denali Therapeutics (DNLI) United States $1.984B 0.00
Kymera Therapeutics (KYMR) United States $1.965B 0.00
CG Oncology (CGON) United States $1.964B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.960B 13.03
Ligand Pharmaceuticals (LGND) United States $1.954B 0.00
Amicus Therapeutics (FOLD) United States $1.928B 208.67
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.894B 0.00
Certara (CERT) United States $1.862B 34.79
Apogee Therapeutics (APGE) United States $1.858B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.805B 0.00
Beam Therapeutics (BEAM) United States $1.734B 0.00
Agios Pharmaceuticals (AGIO) United States $1.714B 0.00
Twist Bioscience (TWST) United States $1.687B 0.00
Disc Medicine (IRON) United States $1.664B 0.00
IDEAYA Biosciences (IDYA) United States $1.636B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.628B 0.00
Biohaven (BHVN) United States $1.576B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.563B 0.00
Janux Therapeutics (JANX) United States $1.492B 0.00
Edgewise Therapeutics (EWTX) United States $1.475B 0.00
Structure Therapeutics (GPCR) United States $1.414B 0.00
89BIO (ETNB) United States $1.409B 0.00
GRAIL (GRAL) United States $1.395B 0.00
Travere Therapeutics (TVTX) United States $1.394B 0.00
Mesoblast (MESO) Australia $1.384B 0.00
Celldex Therapeutics (CLDX) United States $1.352B 0.00
Adaptive Biotechnologies (ADPT) United States $1.343B 0.00
Liquidia Technologies (LQDA) United States $1.330B 0.00
MannKind (MNKD) United States $1.283B 26.38
Vera Therapeutics (VERA) United States $1.252B 0.00
BGM Group (BGM) China $1.248B 0.00
ANI Pharmaceuticals (ANIP) United States $1.241B 12.78
Pacira BioSciences (PCRX) United States $1.207B 11.48
Novavax (NVAX) United States $1.181B 2.75
Dynavax Technologies (DVAX) United States $1.179B 70.14
Viridian Therapeutics (VRDN) United States $1.115B 0.00
Anbio Biotechnology (NNNN) Germany $1.115B 0.00
Mineralys Therapeutics (MLYS) United States $1.064B 0.00
Gyre Therapeutics (GYRE) United States $1.051B 280.25
MiMedx (MDXG) United States $0.993B 24.00
Intellia Therapeutics (NTLA) United States $0.980B 0.00
Geron (GERN) United States $0.943B 0.00
WAVE Life Sciences (WVE) Singapore $0.939B 0.00
NeoGenomics (NEO) United States $0.937B 0.00
CureVac (CVAC) Germany $0.933B 4.52
Syndax Pharmaceuticals (SNDX) United States $0.930B 0.00
Arcus Biosciences (RCUS) United States $0.930B 0.00
Spyre Therapeutics (SYRE) United States $0.908B 0.00
Pharvaris (PHVS) Netherlands $0.857B 0.00
Bicara Therapeutics (BCAX) United States $0.854B 0.00
UniQure (QURE) Netherlands $0.834B 0.00
CorMedix Inc (CRMD) United States $0.832B 55.73
Niagen Bioscience (NAGE) United States $0.800B 112.89
Zymeworks (ZYME) United States $0.799B 0.00
LENZ Therapeutics (LENZ) United States $0.794B 0.00
Oculis Holding AG (OCS) Switzerland $0.784B 0.00
Praxis Precision Medicines (PRAX) United States $0.780B 0.00
Nuvation Bio (NUVB) United States $0.766B 0.00
Nurix Therapeutics (NRIX) United States $0.762B 0.00
Immunome (IMNM) United States $0.736B 0.00
Pharming Group (PHAR) Netherlands $0.714B 0.00
ArriVent BioPharma (AVBP) United States $0.706B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.701B 0.00
Replimune (REPL) United States $0.675B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Anavex Life Sciences (AVXL) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Vir Biotechnology (VIR) United States $0.637B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.636B 0.00
Immatics (IMTX) Germany $0.632B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Arbutus Biopharma (ABUS) United States $0.617B 0.00
AnaptysBio (ANAB) United States $0.609B 0.00
Trevi Therapeutics (TRVI) United States $0.602B 0.00
AbCellera Biologics (ABCL) Canada $0.597B 0.00
Dianthus Therapeutics (DNTH) United States $0.590B 0.00
GH Research (GHRS) Ireland $0.586B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Keros Therapeutics (KROS) United States $0.575B 0.00
Sionna Therapeutics (SION) United States $0.574B 0.00
Cogent Biosciences (COGT) United States $0.564B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.561B 0.00
Eton Pharmaceuticals (ETON) United States $0.543B 0.00
Kura Oncology (KURA) United States $0.540B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.519B 12.02
Tyra Biosciences (TYRA) United States $0.509B 0.00
Upstream Bio (UPB) United States $0.501B 0.00
REGENXBIO (RGNX) United States $0.495B 0.00
Zenas BioPharma (ZBIO) United States $0.479B 0.00
Arvinas (ARVN) United States $0.472B 0.00
Cullinan Therapeutics (CGEM) United States $0.466B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.459B 0.00
Castle Biosciences (CSTL) United States $0.459B 31.16
PureTech Health (PRTC) United States $0.456B 0.00
Sana Biotechnology (SANA) United States $0.451B 0.00
Maze Therapeutics (MAZE) United States $0.445B 0.00
Oric Pharmaceuticals (ORIC) United States $0.423B 0.00
Septerna (SEPN) United States $0.422B 0.00
MBX Biosciences (MBX) United States $0.418B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Tectonic Therapeutic (TECX) United States $0.415B 0.00
Sage Therapeutics (SAGE) United States $0.414B 0.00
Verastem (VSTM) United States $0.411B 0.00
Northwest Biotherapeutics (NWBO) United States $0.411B 0.00
Precigen (PGEN) United States $0.410B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.407B 0.00
Celcuity (CELC) United States $0.407B 0.00
MeiraGTx Holdings (MGTX) United States $0.407B 0.00
Rapport Therapeutics (RAPP) United States $0.406B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.401B 0.00
Kamada (KMDA) Israel $0.387B 23.24
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.385B 0.00
Abivax SA (ABVX) France $0.384B 0.00
Fortrea Holdings (FTRE) United States $0.384B 10.60
Humacyte (HUMA) United States $0.372B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Checkpoint Therapeutics (CKPT) United States $0.363B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.363B 0.00
Myriad Genetics (MYGN) United States $0.362B 0.00
Olema Pharmaceuticals (OLMA) United States $0.353B 0.00
Emergent Biosolutions (EBS) United States $0.353B 0.00
Prothena (PRTA) Ireland $0.353B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.347B 0.00
Erasca (ERAS) United States $0.343B 0.00
Absci (ABSI) United States $0.339B 0.00
ATyr Pharma (ATYR) United States $0.338B 0.00
Abeona Therapeutics (ABEO) United States $0.337B 0.00
Rezolute (RZLT) United States $0.334B 0.00
Alpha Teknova (TKNO) United States $0.333B 0.00
ITeos Therapeutics (ITOS) United States $0.333B 0.00
Fulcrum Therapeutics (FULC) United States $0.330B 0.00
Cidara Therapeutics (CDTX) United States $0.322B 0.00
Cytek Biosciences (CTKB) United States $0.310B 0.00
Tvardi Therapeutics (TVRD) United States $0.308B 0.00
XOMA Royalty (XOMA) United States $0.300B 0.00
Inventiva S.A (IVA) France $0.299B 0.00
Aura Biosciences (AURA) United States $0.299B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.290B 0.00
Entrada Therapeutics (TRDA) United States $0.289B 9.41
Prima BioMed (IMMP) Australia $0.288B 0.00
Candel Therapeutics (CADL) United States $0.272B 0.00
Ocugen (OCGN) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Gossamer Bio (GOSS) United States $0.264B 0.00
Neurogene (NGNE) United States $0.257B 0.00
Terns Pharmaceuticals (TERN) United States $0.257B 0.00
Inozyme Pharma (INZY) United States $0.256B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.250B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.249B 50.62
Lifecore Biomedical (LFCR) United States $0.247B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
Atea Pharmaceuticals (AVIR) United States $0.244B 0.00
DBV Technologies S.A (DBVT) France $0.240B 0.00
MaxCyte (MXCT) United States $0.239B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.239B 0.00
Allogene Therapeutics (ALLO) United States $0.238B 0.00
Cartesian Therapeutics (RNAC) United States $0.237B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.237B 0.00
Third Harmonic Bio (THRD) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.231B 0.00
Astria Therapeutics (ATXS) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Alumis (ALMS) United States $0.229B 0.00
Amarin (AMRN) Ireland $0.228B 0.00
Semper Paratus Acquisition (TVGN) United States $0.226B 0.00
Annexon (ANNX) United States $0.226B 0.00
Solid Biosciences (SLDB) United States $0.224B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.221B 0.00
Adherex Technologies (FENC) United States $0.220B 0.00
Design Therapeutics (DSGN) United States $0.220B 0.00
EnGene Holdings (ENGN) Canada $0.219B 0.00
Aardvark Therapeutics (AARD) United States $0.217B 0.00
GENFIT S.A (GNFT) France $0.217B 0.00
Monopar Therapeutics (MNPR) United States $0.217B 0.00
Adocia (ADOCY) France $0.213B 0.00
Bright Minds Biosciences (DRUG) United States $0.213B 0.00
Nuvectis Pharma (NVCT) United States $0.208B 0.00
Codexis (CDXS) United States $0.204B 0.00
Tango Therapeutics (TNGX) United States $0.202B 0.00
Innate Pharma S.A (IPHA) France $0.201B 0.00
BioStem Technologies (BSEM) $0.200B 8.16
Actuate Therapeutics (ACTU) United States $0.198B 0.00
Cardiff Oncology (CRDF) United States $0.192B 0.00
CARGO Therapeutics (CRGX) United States $0.189B 0.00
Urogen Pharma (URGN) United States $0.188B 0.00
Kodiak Sciences (KOD) United States $0.187B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.187B 0.00
ScPharmaceuticals (SCPH) United States $0.185B 0.00
Inhibrx Biosciences (INBX) United States $0.182B 0.11
Eledon Pharmaceuticals (ELDN) United States $0.181B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.178B 0.00
Galena Biopharma (SLS) United States $0.176B 0.00
DiaMedica Therapeutics (DMAC) United States $0.174B 0.00
INmune Bio (INMB) United States $0.172B 0.00
CytomX Therapeutics (CTMX) United States $0.172B 4.44
AC Immune (ACIU) Switzerland $0.170B 0.00
Anika Therapeutics (ANIK) United States $0.169B 0.00
Voyager Therapeutics (VYGR) United States $0.165B 0.00
Prime Medicine (PRME) United States $0.161B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Puma Biotechnology (PBYI) United States $0.161B 4.22
Tiziana Life Sciences (TLSA) United Kingdom $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
BioAge Labs (BIOA) United States $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.139B 0.00
Fate Therapeutics (FATE) United States $0.138B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.137B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.137B 0.00
Editas Medicine (EDIT) United States $0.136B 0.00
TuHURA Biosciences (HURA) United States $0.131B 0.00
Compugen (CGEN) Israel $0.131B 0.00
Greenwich LifeSciences (GLSI) United States $0.131B 0.00
Alector (ALEC) United States $0.131B 0.00
Ventyx Biosciences (VTYX) United States $0.130B 0.00
Nkarta (NKTX) United States $0.125B 0.00
Seer (SEER) United States $0.124B 0.00
InflaRx (IFRX) Germany $0.122B 0.00
EXoZymes (EXOZ) United States $0.122B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Black Diamond Therapeutics (BDTX) United States $0.117B 34.33
Neumora Therapeutics (NMRA) United States $0.116B 0.00
Sangamo Therapeutics (SGMO) United States $0.115B 0.00
Rapt Therapeutics (RAPT) United States $0.114B 0.00
Kyverna Therapeutics (KYTX) United States $0.107B 0.00
Sagimet Biosciences (SGMT) United States $0.105B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.105B 0.00
Agenus (AGEN) United States $0.104B 0.00
Caribou Biosciences (CRBU) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.101B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
C4 Therapeutics (CCCC) United States $0.097B 0.00
Medicus Pharma (MDCX) United States $0.096B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.095B 0.00
Genelux (GNLX) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Invivyd (IVVD) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.091B 0.00
Cabaletta Bio (CABA) United States $0.090B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Whitehawk Therapeutics (WHWK) United States $0.089B 0.00
Immunic (IMUX) United States $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
I-Mab (IMAB) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Elicio Therapeutics (ELTX) United States $0.082B 0.00
Pliant Therapeutics (PLRX) United States $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
Climb Bio (CLYM) United States $0.081B 0.00
Senti Biosciences (SNTI) United States $0.080B 0.00
Alto Neuroscience (ANRO) United States $0.079B 0.00
IO Biotech (IOBT) Denmark $0.079B 0.00
Genenta Science S.p.A (GNTA) Italy $0.079B 0.00
Adagene (ADAG) China $0.077B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.074B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Jasper Therapeutics (JSPR) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
PDS Biotechnology (PDSB) United States $0.072B 0.00
IGM Biosciences (IGMS) United States $0.072B 0.00
Zura Bio (ZURA) United States $0.071B 0.00
Tenaya Therapeutics (TNYA) United States $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Elutia (ELUT) United States $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
Adlai Nortye (ANL) Cayman Islands $0.067B 0.00
Exicure (XCUR) United States $0.066B 0.00
Citius Oncology (CTOR) United States $0.065B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.065B 0.00
Skye Bioscience (SKYE) United States $0.064B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
OKYO Pharma (OKYO) $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
Celularity (CELU) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.058B 0.00
Renovaro (RENB) United States $0.057B 0.00
TELA Bio (TELA) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.057B 0.00
Ikena Oncology (IKNA) United States $0.056B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
Biomea Fusion (BMEA) United States $0.054B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Kalaris Therapeutics (KLRS) United States $0.053B 0.00
Immuneering (IMRX) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Fortress Biotech (FBIO) United States $0.051B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.051B 0.00
Werewolf Therapeutics (HOWL) United States $0.050B 0.00
Quince Therapeutics (QNCX) United States $0.050B 0.00
Forte Biosciences (FBRX) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Mersana Therapeutics (MRSN) United States $0.049B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
PepGen (PEPG) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Connect Biopharma Holdings (CNTB) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Atara Biotherapeutics (ATRA) United States $0.042B 0.00
Kronos Bio (KRON) United States $0.042B 0.00
Annovis Bio (ANVS) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Spero Therapeutics (SPRO) United States $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Boundless Bio (BOLD) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Aligos Therapeutics (ALGS) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.033B 0.00
Quantum Biopharma (QNTM) Canada $0.033B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.033B 0.00
Scilex Holding (SCLX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.032B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
OnKure Therapeutics (OKUR) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Advanced Biomed (ADVB) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
Vor Biopharma (VOR) $0.023B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.022B 0.00
Clene (CLNN) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Curis (CRIS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
ABVC BioPharma (ABVC) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
X4 Pharmaceuticals (XFOR) United States $0.019B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Equillium (EQ) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
IN8bio (INAB) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Imunon (IMNN) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Eyenovia (EYEN) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00